AIEC-dependent pathogenic Th17 cell transdifferentiation in Crohn's disease is suppressed by rfaP and ybaT deletion

Gut Microbes. 2024 Jan-Dec;16(1):2380064. doi: 10.1080/19490976.2024.2380064. Epub 2024 Jul 29.

Abstract

Mucosal enrichment of the Adherent-Invasive E. coli (AIEC) pathotype and the expansion of pathogenic IFNγ-producing Th17 (pTh17) cells have been linked to Crohn's Disease (CD) pathogenesis. However, the molecular pathways underlying the AIEC-dependent pTh17 cell transdifferentiation in CD patients remain elusive. To this aim, we created and functionally screened a transposon AIEC mutant library of 10.058 mutants to identify the virulence determinants directly implicated in triggering IL-23 production and pTh17 cell generation. pTh17 cell transdifferentiation was assessed in functional assays by co-culturing AIEC-infected human dendritic cells (DCs) with autologous conventional Th17 (cTh17) cells isolated from blood of Healthy Donors (HD) or CD patients. AIEC triggered IL-23 hypersecretion and transdifferentiation of cTh17 into pTh17 cells selectively through the interaction with CD-derived DCs. Moreover, the chronic release of IL-23 by AIEC-colonized DCs required a continuous IL-23 neutralization to significantly reduce the AIEC-dependent pTh17 cell differentiation. The multi-step screenings of the AIEC mutant's library revealed that deletion of ybaT or rfaP efficiently hinder the IL-23 hypersecretion and hampered the AIEC-dependent skewing of protective cTh17 into pathogenic IFNγ-producing pTh17 cells. Overall, our findings indicate that ybaT (inner membrane transport protein) and rfaP (LPS-core heptose kinase) represent novel and attractive candidate targets to prevent chronic intestinal inflammation in CD.

Keywords: AIEC; Crohn’s disease; IL-23; pathogenic Th17 cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Transdifferentiation* / genetics
  • Crohn Disease* / genetics
  • Crohn Disease* / immunology
  • Dendritic Cells* / immunology
  • Escherichia coli Proteins / genetics
  • Escherichia coli Proteins / metabolism
  • Escherichia coli* / genetics
  • Escherichia coli* / immunology
  • Gene Deletion
  • Humans
  • Interferon-gamma / genetics
  • Interferon-gamma / immunology
  • Interferon-gamma / metabolism
  • Interleukin-23* / genetics
  • Interleukin-23* / immunology
  • Interleukin-23* / metabolism
  • Th17 Cells* / immunology
  • Virulence Factors / genetics
  • Virulence Factors / metabolism

Substances

  • Interleukin-23
  • Escherichia coli Proteins
  • Interferon-gamma
  • Virulence Factors

Grants and funding

This study was financially supported by Cariplo Foundation-Biomedical Research Conducted by Young Researchers (GR-2017–0816) to M.P, C.C., and F.C, by the Department of Biosciences – University of Milan (funding program for younger staff members “Linea 2”) to M.P.; and by University of Milan (SEED grant-funding program for interdepartmental projects) to F.C. and M.P.; and partly funded by Italy’s Ministry of Health and the current IRCCS research programme to F.C.